Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells

Brain, Behavior, and Immunity

Volumn 30, Issue , 2013, Pages 54-60

  Souza Moreira, Luciana ^a   Delgado Maroto, Virginia ^a   Morell, Maria ^a   O'Valle, Francisco ^b   Del Moral, Raimundo G ^b   Gonzalez Rey, Elena ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b Medical School of Granada   (Spain)

Author keywords

Autoimmunity; Neuroinflammation; Regulatory T cells; Tolerance

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GHRELIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; DISEASE SEVERITY; DOWN REGULATION; INCIDENCE; INFLAMMATORY INFILTRATE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPINAL CORD; SYSTEMIC THERAPY; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; THERAPY EFFECT;

ANIMALS; CYTOKINES; DOWN-REGULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FORKHEAD TRANSCRIPTION FACTORS; GHRELIN; INFLAMMATION; MICE; SPINAL CORD; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 84876837147     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.01.080     Document Type: Article

References (24)

1. Baatar D., Patel K., Taub D.D. The effects of ghrelin on inflammation and the immune system. Mol. Cell. Endocrinol. 2011, 340:44-58.
2. Castro A., Jerez M.J., Gil C., Martinez A. Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors. Med. Res. Rev. 2005, 25:229-244.
3. Chen C.Y., Asakawa A., Fujimiya M., Lee S.D., Inui A. Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol. Rev. 2009, 61:430-481.
4. Chorny A., Anderson P., Gonzalez-Rey E., Delgado M. Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria. J. Immunol. 2008, 180:8369-8377.
5. Dixit V.D., Schaffer E.M., Pyle R.S., Collins G.D., Sakthivel S.K., Palaniappan R., Lillard J.W., Taub D.D. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Invest. 2004, 114:57-66.
6. Dixit V.D., Yang H., Cooper-Jenkins A., Giri B.B., Patel K., Taub D.D. Reduction of T cell-derived ghrelin enhances proinflammatory cytokine expression: implications for age-associated increases in inflammation. Blood 2009, 113:5202-5205.
7. Dixit V.D., Yang H., Sun Y., Weeraratna A.T., Youm Y.H., Smith R.G., Taub D.D. Ghrelin promotes thymopoiesis during aging. J. Clin. Invest. 2007, 117:2778-2790.
8. Gonzalez-Rey E., Chorny A., Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 2006, 130:1707-1720.
9. Gonzalez-Rey E., Chorny A., Delgado M. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat. Rev. Immunol. 2007, 7:52-63.
10. Goverman J. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 2009, 9:393-407.
11. Groux H., Cottrez F. The complex role of interleukin-10 in autoimmunity. J. Autoimmun. 2003, 20:281-285.
12. Kluver H., Barrera E. A method for the combined staining of cells and fibers in the nervous system. J. Neuropathol. Exp. Neurol. 1953, 12:400-403.
13. Kodama T., Ashitani J., Matsumoto N., Kangawa K., Nakazato M. Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection. Pulm. Pharmacol. Ther. 2008, 21:774-779.
14. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 2002, 169:4712-4716.
15. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:566-573.
16. Kong W., Yen J.H., Ganea D. Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis. Brain Behav. Immun. 2011, 25:872-882.
17. Lee J.Y., Oh T.H., Yune T.Y. Ghrelin inhibits hydrogen peroxide-induced apoptotic cell death of oligodendrocytes via ERK and p38MAPK signalling. Endocrinology 2011, 152:2377-2386.
18. Li W.G., Gavrila D., Liu X., Wang L., Gunnlaugsson S., Stoll L.L., McCormick M.L., Sigmund C.D., Tang C., Weintraub N.L. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 2004, 109:2221-2226.
19. + regulatory T cells. Dokl. Biol. Sci. 2011, 440:343-346.
20. Sibilia V., Pagani F., Mrak E., Dieci E., Tulipano G., Ferrucci F. Pharmacological characterization of the ghrelin receptor mediating its inhibitory action on inflammatory pain in rats. Amino Acids 2012, 43:1751-1759.
21. Theil M.M., Miyake S., Mizuno M., Tomi C., Croxford J.L., Hosoda H., Theil J., von Horsten S., Yokote H., Chiba A., Lin Y., Oki S., Akamizu T., Kangawa K., Yamamura T. Suppression of experimental autoimmune encephalomyelitis by ghrelin. J. Immunol. 2009, 183:2859-2866.
22. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004, 199:971-979.
23. Wu R., Dong W., Qiang X., Wang H., Blau S.A., Ravikumar T.S., Wang P. Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats. Crit. Care Med. 2009, 37:2421-2426.
24. Xia Q., Pang W., Pan H., Zheng Y., Kang J.S., Zhu S.G. Effects of ghrelin on the proliferation and secretion of splenic T lymphocytes in mice. Regul. Pept. 2004, 122:173-178.